Verheijden; Gijsbertus Franciscus Maria
Patent Applications and Registrations
Patent applications and USPTO patent grants for Verheijden; Gijsbertus Franciscus Maria.The latest application filed is for "anti-sirp alpha antibodies".
- Verheijden; Gijsbertus Franciscus Maria - Nijmegen NL
- Verheijden; Gijsbertus Franciscus Maria - Heischouw NL
- Verheijden, Gijsbertus Franciscus Maria - Oss NL
| Patent | Date |
|---|---|
| Duocarmycin ADCs showing improved in vivo antitumor activity Grant 11,382,982 - Dokter , et al. July 12, 2 | 2022-07-12 |
| Anti-sirp Alpha Antibodies App 20220195063 - VERHEIJDEN; Gijsbertus Franciscus Maria ; et al. | 2022-06-23 |
| Anti-SIRP.alpha. antibodies Grant 11,274,159 - Verheijden , et al. March 15, 2 | 2022-03-15 |
| Humanized Anti-sirp Alpha Antibodies App 20210388107 - VERHEIJDEN; Gijsbertus Franciscus Maria | 2021-12-16 |
| Anti-sirp Alpha Antibodies App 20210070874 - VERHEIJDEN; Gijsbertus Franciscus Maria ; et al. | 2021-03-11 |
| Duocarmycin ADCs showing improved in vivo antitumor activity Grant 10,603,387 - Dokter , et al. | 2020-03-31 |
| Duocarmycin Adcs Showing Improved In Vivo Antitumor Activity App 20190314513 - DOKTER; Willem ; et al. | 2019-10-17 |
| Duocarmycin Adcs Showing Improved In Vivo Antitumor Activity App 20180140711 - Dokter; Willem ; et al. | 2018-05-24 |
| Duocarmycin Adcs Showing Improved In Vivo Antitumor Activity App 20170014525 - DOKTER; Willem ; et al. | 2017-01-19 |
| Duocarmycin ADCS showing improved in vivo antitumor activity Grant 9,421,278 - Dokter , et al. August 23, 2 | 2016-08-23 |
| Duocarmycin Adcs Showing Improved In Vivo Antitumor Activity App 20160008486 - DOKTER; Willem ; et al. | 2016-01-14 |
| Peptides for use in immunotherapy of autoimmune diseases Grant 6,964,766 - Verheijden , et al. November 15, 2 | 2005-11-15 |
| Novel peptides for use in treatment of T-cell mediated cartilage destruction in autoimmune diseases App 20020177554 - Verheijden, Gijsbertus Franciscus Maria ; et al. | 2002-11-28 |
| Peptides suitable for use in antigen specific immunosuppressive therapy Grant 6,184,204 - Boots , et al. February 6, 2 | 2001-02-06 |
| Proteins and novel peptides derived from autoantigen for use in immunotherapy of autoimmune diseases Grant 5,843,449 - Boots , et al. December 1, 1 | 1998-12-01 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 